Prometheus Biosciences, antibody therapies development, $190M
Neurelis, epilepsy candidates, $114M Series D with LYZZ Capital, Philos & Partners, Cormorant Asset Management
Ventyx Biosciences, treating autoimmune diseases, $114M with venBio Partners, Third Point, Orbimed, Logos Capital
BlossomHill Therapeutics, oncology and autoimmune, $71M Series A with Orbimed, Cormorant Asset Management, Hercules Bioventure Partners
Janux Therapeutics, immunotherapies for tumors, $56M Series A with Orbimed, Avalon Ventures, RA Capital
Seqster, digital health SaaS, $11M
Founders First Capital, underrepresented founder funding, $9M Series A with Rockefeller Foundation, Kauffman Foundation, Surdna Foundation
CourseKey, trade school management software, $9M Series A with SignalFire, Builders VC
AdigicaHealth, consumer healthcare products, $1M
RevVentures, performance marketing ecosystem, $1M with KEY Investment Partners and Phyto Partners